-
公开(公告)号：US20090062233A1
公开(公告)日：2009-03-05
申请号：US12228029
申请日：2008-08-08
申请人： Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
发明人： Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
IPC分类号： A61K31/718 , A61P17/02
CPC分类号： A61L31/042 , A61K9/0014 , A61K9/14 , A61K9/19 , A61K31/718 , A61K31/738 , A61K45/06 , A61L24/0015 , A61L24/0036 , A61L24/0073 , A61L24/08 , A61L24/104 , A61L26/0023 , A61L26/0085 , A61L31/045 , A61L31/125 , A61L2300/406 , A61L2400/04 , A61L2430/34 , C08B30/00 , C08B30/20 , C08B31/00 , C08B31/003 , C08B31/02 , C08B31/04 , C08B31/08 , C08B31/10 , C08B31/12 , C08B31/16 , C08B31/18 , C08B33/02 , C08B33/04 , C08B33/06 , C08B35/02 , C08B35/04 , C08B35/06 , C08L3/04 , C08L3/18 , C08L89/06 , Y10T428/2982
摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
摘要翻译： 当作为生物相容性改性淀粉应用于动物组织时，用于生物相容性止血，生物相容性粘附预防，组织愈合促进，可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。
-
公开(公告)号：US20130251996A1
公开(公告)日：2013-09-26
申请号：US13894396
申请日：2013-05-14
申请人： Xin JI , Cheng Xing , Xueshen Shi , Jianping Chen
发明人： Xin JI , Cheng Xing , Xueshen Shi , Jianping Chen
IPC分类号： A61L24/08 , A61L26/00 , A61K31/738 , A61K31/718
CPC分类号： A61L31/042 , A61K9/0014 , A61K9/14 , A61K9/19 , A61K31/718 , A61K31/738 , A61K45/06 , A61L24/0015 , A61L24/0036 , A61L24/0073 , A61L24/08 , A61L24/104 , A61L26/0023 , A61L26/0085 , A61L31/045 , A61L31/125 , A61L2300/406 , A61L2400/04 , A61L2430/34 , C08B30/00 , C08B30/20 , C08B31/00 , C08B31/003 , C08B31/02 , C08B31/04 , C08B31/08 , C08B31/10 , C08B31/12 , C08B31/16 , C08B33/02 , C08B33/04 , C08B33/06 , C08B35/02 , C08B35/04 , C08B35/06 , C08L3/04 , C08L3/18 , C08L89/06 , Y10T428/2982
摘要： A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
摘要翻译： 当将生物相容的改性淀粉作为生物相容的改性淀粉应用于动物的组织时，布置了改良的淀粉材料用于生物相容性止血，生物相容性粘附防止，组织愈合促进，可吸收的外科伤口密封和组织粘合。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。
-
公开(公告)号：US09687501B2
公开(公告)日：2017-06-27
申请号：US13894396
申请日：2013-05-14
申请人： Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
发明人： Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
IPC分类号： A61K31/718 , A61L24/00 , A61L26/00 , A61K9/14 , C08L3/18 , C08L3/04 , C08L89/06 , C08B31/12 , C08B31/08 , C08B31/02 , C08B33/04 , C08B31/10 , C08B31/16 , C08B35/02 , C08B33/06 , C08B35/06 , C08B35/04 , C08B33/02 , C08B31/04 , C08B30/20 , C08B31/00 , C08B30/00 , A61K31/738 , A61L24/08 , A61K45/06 , A61K9/19 , C08B31/06 , A61K9/00
CPC分类号： A61L31/042 , A61K9/0014 , A61K9/14 , A61K9/19 , A61K31/718 , A61K31/738 , A61K45/06 , A61L24/0015 , A61L24/0036 , A61L24/0073 , A61L24/08 , A61L24/104 , A61L26/0023 , A61L26/0085 , A61L31/045 , A61L31/125 , A61L2300/406 , A61L2400/04 , A61L2430/34 , C08B30/00 , C08B30/20 , C08B31/00 , C08B31/003 , C08B31/02 , C08B31/04 , C08B31/08 , C08B31/10 , C08B31/12 , C08B31/16 , C08B33/02 , C08B33/04 , C08B33/06 , C08B35/02 , C08B35/04 , C08B35/06 , C08L3/04 , C08L3/18 , C08L89/06 , Y10T428/2982
摘要： A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
-
-
搜索结果
3 条记录 (耗时 0.009 秒)
